Literature DB >> 25005102

Purification, crystallization and preliminary X-ray crystallographic analysis of the UDP-N-acetylmuramoyl-tripeptide-D-alanyl-D-alanine ligase (MurF) from Acinetobacter baumannii.

Young Jun An1, Chang-Sook Jeong1, Jeong Hee Yu2, Kyung Min Chung2, Sun-Shin Cha1.   

Abstract

The emergence and global spread of multidrug-resistant Acinetobacter baumannii strains are major threats to public health. Inhibition of peptidoglycan biosynthesis is an effective strategy for the development of antibiotics. The ATP-dependent UDP-N-acetylmuramoyl-tripeptide-D-alanyl-D-alanine ligase (MurF) that is responsible for the last step of peptidoglycan biosynthesis is a validated target for the development of antibiotics. Crystals of A. baumannii MurF in complex with ATP were grown by the microbatch crystallization method at 295 K. The crystals belonged to space group P322₁, with unit-cell parameters a=b=85.42, c=129.86 Å. Assuming the presence of one molecule in the asymmetric unit, the solvent content was estimated to be about 54.32%.

Entities:  

Keywords:  Acinetobacter baumannii; MurF

Mesh:

Substances:

Year:  2014        PMID: 25005102      PMCID: PMC4089545          DOI: 10.1107/S2053230X14009984

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  19 in total

1.  Crystal structure of Escherichia coli UDPMurNAc-tripeptide d-alanyl-d-alanine-adding enzyme (MurF) at 2.3 A resolution.

Authors:  Y Yan; S Munshi; B Leiting; M S Anderson; J Chrzas; Z Chen
Journal:  J Mol Biol       Date:  2000-12-01       Impact factor: 5.469

2.  Structure of MurF from Streptococcus pneumoniae co-crystallized with a small molecule inhibitor exhibits interdomain closure.

Authors:  Kenton L Longenecker; Geoffrey F Stamper; Philip J Hajduk; Elizabeth H Fry; Clarissa G Jakob; John E Harlan; Rohinton Edalji; Diane M Bartley; Karl A Walter; Larry R Solomon; Thomas F Holzman; Yu Gui Gu; Claude G Lerner; Bruce A Beutel; Vincent S Stoll
Journal:  Protein Sci       Date:  2005-12       Impact factor: 6.725

3.  Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline.

Authors:  F S Taccone; H Rodriguez-Villalobos; D De Backer; V De Moor; J Deviere; J-L Vincent; F Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

4.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

5.  Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features.

Authors:  J M Cisneros; M J Reyes; J Pachón; B Becerril; F J Caballero; J L García-Garmendía; C Ortiz; A R Cobacho
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

6.  Kinetic mechanism of the Escherichia coli UDPMurNAc-tripeptide D-alanyl-D-alanine-adding enzyme: use of a glutathione S-transferase fusion.

Authors:  M S Anderson; S S Eveland; H R Onishi; D L Pompliano
Journal:  Biochemistry       Date:  1996-12-17       Impact factor: 3.162

Review 7.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 8.  Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality.

Authors:  H Seifert; A Strate; G Pulverer
Journal:  Medicine (Baltimore)       Date:  1995-11       Impact factor: 1.889

9.  Biochemical evidence for the formation of a covalent acyl-phosphate linkage between UDP-N-acetylmuramate and ATP in the Escherichia coli UDP-N-acetylmuramate:L-alanine ligase-catalyzed reaction.

Authors:  P J Falk; K M Ervin; K S Volk; H T Ho
Journal:  Biochemistry       Date:  1996-02-06       Impact factor: 3.162

10.  Structure-activity relationships of new cyanothiophene inhibitors of the essential peptidoglycan biosynthesis enzyme MurF.

Authors:  Martina Hrast; Samo Turk; Izidor Sosič; Damijan Knez; Christopher P Randall; Hélène Barreteau; Carlos Contreras-Martel; Andréa Dessen; Alex J O'Neill; Dominique Mengin-Lecreulx; Didier Blanot; Stanislav Gobec
Journal:  Eur J Med Chem       Date:  2013-05-21       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.